Short interest is the number of shares that have been sold short but have not yet been covered or closed out. Short selling is when a trader sells shares of a company they do not own, with the hope ...

Dr. Duckworth, a psychologist, is the author of “Grit” and the forthcoming book “Situated: Finding the People and Places That Bring Out Your Best.” There is a children’s story I used to read to my ...

When I last covered the self-styled TechBio company Recursion Pharmaceuticals, Inc. (RXRX) in early October, I was attempting to find reasons why the company's share price was on the rise, up from ~$4 ...

Dec 8 (Reuters) - Recursion Pharma (RXRX.O), opens new tab, which uses artificial intelligence to discover new drug candidates, said on Monday its experimental oral drug helped reduce abnormal growths ...

The 2026 World Cup draw will be held before the field is settled in full, as December 5 gives every nation its path to the World Cup Final. The draw will be held on December 5 in Washington, DC, and ...

Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.71. LONDON — In the year-plus since Najat Khan joined the AI-focused drug ...

Forbes contributors publish independent expert analyses and insights. We set an example for a better future via education and research. The possible shift back to entirely in-person work has sparked a ...

To use artificial intelligence at work, you can begin by imagining the things you can stop doing, the things you can do better and the new things you can do. Imagine the future of your job. Now ...

Recursion Pharmaceuticals (RXRX 3.50%), a biotech focused on artificial intelligence (AI), became a publicly traded company in 2021 -- a time when AI did not grab nearly as much attention (if any at ...

Recursion Pharmaceuticals uses AI to expedite the laborious process of developing drugs. The company could benefit from industry-wide regulatory changes as well as its own clinical progress. However, ...

Recursion Pharmaceuticals uses AI to expedite the laborious process of developing drugs. The company could benefit from industry-wide regulatory changes as well as its own clinical progress. However, ...